{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:10:53Z","timestamp":1787101853543,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>In an era of head and neck oncology where HPV status will soon dictate patient management, reliable HPV detection is critical. P16 immunohistochemistry (IHC) is currently recommended as the test of choice for oropharyngeal squamous cell carcinomas (OPSCCs). The purpose of this study was to determine the performance characteristics of p16 IHC based on a large clinical experience of squamous cell carcinomas (SCC) arising from HPV hot-spot regions of the head and neck. Consecutive OPSCCs, sinonasal SCCs, and metastatic SCCs of unknown primary sites were evaluated for the presence of HPV by p16 IHC and PCR-based HPV DNA testing as part of clinical care. For discrepant cases, high-risk HPV E6\/E7 mRNA in situ hybridization (ISH) and, when possible, matrix-assisted laser desorption\/ionization\u2014time of flight (MALDI-TOF) mass spectrometry (MassArray) genotyping were performed. 746 cancers underwent HPV testing by p16 IHC and DNA PCR genotyping. There was a 95.6% concordance between the 2 assays. Of the 33 discrepant cases, 32 cases (4.3%) were p16 positive but HPV DNA negative. In these cases, 68% were positive for mRNA ISH, invariably related to a non-16 HPV genotype. P16 IHC had an overall accuracy of 98.8%, a sensitivity of 99.8%, and a specificity of 92.1%. P16 IHC is a sensitive and specific assay for determining HPV status. HPV DNA PCR appears vulnerable to HPV genotype diversity and is prone to missing rare non-16 genotypes. HPV mRNA ISH is a practical and reliable direct measure of HPV that may help eliminate the small number of false-positive p16 cases and avoid potential patient harm related to erroneous HPV classification.<\/jats:p>","DOI":"10.1097\/pas.0000000000002204","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T11:06:10Z","timestamp":1710414370000},"page":"581-587","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Reappraisal of p16 for Determining HPV Status of Head and Neck Carcinomas Arising in HPV Hotspots"],"prefix":"10.1097","volume":"48","author":[{"given":"Swati","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Paniz-Mondolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JOP.18.00433","article-title":"Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline Endorsement Summary of the CAP Guideline","volume":"14","author":"Fakhry","year":"2018","journal-title":"J Oncol Pract"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1634\/theoncologist.2020-0303","article-title":"Optimizing treatment de-escalation in head and neck cancer: current and future perspectives","volume":"26","author":"Rosenberg","year":"2021","journal-title":"Oncologist"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1158\/1078-0432.CCR-22-0562","article-title":"Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma","volume":"28","author":"Berger","year":"2022","journal-title":"Clin Cancer Res"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamaoto.2022.3282","article-title":"Association of pretreatment circulating tumor tissue-modified viral HPV DNA with clinicopathologic factors in HPV-positive oropharyngeal cancer","volume":"148","author":"Rettig","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1158\/0008-5472.CAN-11-3934","article-title":"Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement","volume":"72","author":"Holzinger","year":"2012","journal-title":"Cancer Res"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.humpath.2013.09.006","article-title":"African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis","volume":"45","author":"Isayeva","year":"2014","journal-title":"Hum Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.oraloncology.2019.02.006","article-title":"Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: exposing the limitations of conventional p16 immunostaining","volume":"90","author":"El-Salem","year":"2019","journal-title":"Oral Oncol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/dc.24603","article-title":"Liquid phase human papillomavirus genotype analysis of aspirated metastatic head and neck squamous cell carcinoma: fine needle aspiration supernatant is a rich source of tumor DNA that can increase the diagnostic yield","volume":"49","author":"Hao","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/ctg.2016.8","article-title":"Anal neoplasia in inflammatory bowel disease is associated with HPV and perianal disease","volume":"7","author":"Ruel","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-6442-0_5","article-title":"The MassARRAY((R)) system for targeted SNP genotyping","volume":"1492","author":"Ellis","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1309\/AJCPWTZDT0Q7DOVI","article-title":"A new PCR-based mass spectrometry system for high-risk HPV, part I: methods","volume":"136","author":"Yi","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.oraloncology.2014.05.004","article-title":"Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas","volume":"50","author":"Westra","year":"2014","journal-title":"Oral Oncol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.3390\/ijms23158395","article-title":"Therapeutic vaccines for HPV-associated oropharyngeal and cervical cancer: the next de-intensification strategy?","volume":"23","author":"Morand","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"104652","DOI":"10.1016\/j.oraloncology.2020.104652","article-title":"Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: current state and future directions","volume":"105","author":"Bigelow","year":"2020","journal-title":"Oral Oncol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamaoto.2023.1937","article-title":"Performance of liquid biopsy for diagnosis and surveillance of human papillomavirus-associated oropharyngeal cancer","volume":"149","author":"Ferrandino","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/PAS.0000000000002134","article-title":"Circulating tumor HPV DNA in patients with head and neck carcinoma: correlation with HPV genotyping","volume":"48","author":"Mijares","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J Clin Oncol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2022.02.012","article-title":"Detectable postoperative circulating tumor human papillomavirus DNA and association with recurrence in patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"113","author":"Routman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","article-title":"Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis","volume":"24","author":"Mehanna","year":"2023","journal-title":"Lancet Oncol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.18.00684","article-title":"Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline","volume":"36","author":"Fakhry","year":"2018","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"R29-20250608","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s12105-012-0372-5","article-title":"HPV detection methods in head and neck cancer","volume":"6","author":"Venuti","year":"2012","journal-title":"Head Neck Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12879-022-07654-2","article-title":"Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer","volume":"22","author":"Simoens","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"105109","DOI":"10.1016\/j.oraloncology.2020.105109","article-title":"Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance","volume":"113","author":"Mashiana","year":"2021","journal-title":"Oral Oncol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaoncol.2019.0439","article-title":"Association of oral human papillomavirus DNA persistence with cancer progression after primary treatment for oral cavity and oropharyngeal squamous cell carcinoma","volume":"5","author":"Fakhry","year":"2019","journal-title":"JAMA Oncol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/PAS.0b013e318265fb2b","article-title":"Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6\/E7 mRNA in situ hybridization method","volume":"36","author":"Bishop","year":"2012","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:06:04Z","timestamp":1749413164000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002204","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}